Spots Global Cancer Trial Database for ketoconazole
Every month we try and update this database with for ketoconazole cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas | NCT04869449 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Ketoconazole | 18 Years - | Milton S. Hershey Medical Center | |
| Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma | NCT02075177 | Recurrent Neuro... Neuroblastoma | Fenretinide Lym... Ketoconazole | - | South Plains Oncology Consortium | |
| A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). | NCT01021358 | Lymphoma Chronic Lymphoc... Solid Tumors | ABT-263 Ketoconazole | 18 Years - | Abbott | |
| Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | NCT00003249 | Unspecified Adu... | carboxyamidotri... chemotherapy ketoconazole | 18 Years - | National Cancer Institute (NCI) | |
| Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | NCT00559481 | Prostate Cancer | dexamethasone ketoconazole therapeutic hyd... pharmacological... | - | Roswell Park Cancer Institute | |
| Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00238225 | Unspecified Adu... | calcitriol dexamethasone ketoconazole | 18 Years - | Roswell Park Cancer Institute | |
| Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy | NCT00309894 | Prostate Cancer | sargramostim ketoconazole therapeutic hyd... | - 120 Years | University of California, San Francisco | |
| Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | NCT00559481 | Prostate Cancer | dexamethasone ketoconazole therapeutic hyd... pharmacological... | - | Roswell Park Cancer Institute | |
| A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199 | NCT01969669 | Non-Hodgkin's L... | ABT-199 Ketoconazole | 18 Years - 99 Years | AbbVie | |
| Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | NCT00559481 | Prostate Cancer | dexamethasone ketoconazole therapeutic hyd... pharmacological... | - | Roswell Park Cancer Institute | |
| Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) | NCT01026415 | Carcinomas Disease, Hodgki... Lymphoma, Large... Lymphoma, Non-H... Neoplasms | brentuximab ved... rifampin midazolam ketoconazole brentuximab ved... | 18 Years - | Seagen Inc. | |
| Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors | NCT00096317 | Unspecified Adu... | ixabepilone ketoconazole | 18 Years - 120 Years | Montefiore Medical Center | |
| Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas | NCT04869449 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Ketoconazole | 18 Years - | Milton S. Hershey Medical Center | |
| Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer | NCT00673127 | Prostate Cancer | Ketoconazole, H... | 18 Years - | Dana-Farber Cancer Institute | |
| Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | NCT00586898 | Prostate Cancer Hormonal Cyclin... | GnRH Ketoconazole Bicalutamide Testosterone tr... Estrogen transd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours | NCT00750425 | Advanced Solid ... | cediranib (RECE... | 18 Years - | AstraZeneca | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma | NCT00295919 | Neuroblastoma | fenretinide lip... ketoconazole laboratory biom... pharmacological... | 0 Years - 30 Years | Children's Hospital Los Angeles | |
| Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma | NCT01454076 | Nonhematologic ... Lymphoma | Ixazomib 2.5 mg Ixazomib 4 mg C... Ixazomib 4 mg C... Ketoconazole Rifampin Clarithromycin Ixazomib 4 mg C... | 18 Years - | Takeda | |
| Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | NCT00014352 | Prostate Cancer Thromboembolism | docetaxel doxorubicin hyd... estramustine ph... ketoconazole warfarin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma | NCT02075177 | Recurrent Neuro... Neuroblastoma | Fenretinide Lym... Ketoconazole | - | South Plains Oncology Consortium | |
| Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00460031 | Prostate Cancer | ketoconazole lenalidomide therapeutic hyd... | 18 Years - | Case Comprehensive Cancer Center | |
| Ketoconazole and Dexamethasone in Prostate Cancer | NCT01036594 | Prostate Cancer | Ketoconazole Hydrocortisone Dexamethasone | 18 Years - | University of California, San Francisco | |
| Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study | NCT00870714 | Prostate Cancer | Docetaxel Ketoconazole | 18 Years - | Kansas City Veteran Affairs Medical Center | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors | NCT01340846 | Cancer | Warfarin Ketoconazole Gemfibrozil GSK2118436 150m... GSK2118436 75mg | 18 Years - | GlaxoSmithKline | |
| Study of Rapamycin Plus Ketoconazole in Advanced Cancers | NCT00708591 | Advanced Cancer | Rapamycin Ketoconazole | 18 Years - | University of Chicago | |
| Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy | NCT00895310 | Prostate Cancer | Ketoconazole Hydrocortisone | 18 Years - | University of California, Davis | |
| VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK | NCT01205230 | Cancer | pazopanib | 18 Years - | GlaxoSmithKline | |
| Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer | NCT00953576 | Prostate Cancer | ketoconazole hydrocortisone dutasteride lapatinib | 18 Years - | Dana-Farber Cancer Institute | |
| 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer | NCT00859781 | Prostate Cancer | 177Lu-J591 Ketoconazole Hydrocortisone 111In-J591 | 18 Years - | Weill Medical College of Cornell University | |
| A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies | NCT01267084 | Neoplasm Metast... | Trabectedin Ketoconazole Dexamethasone o... | 18 Years - | Janssen Research & Development, LLC | |
| Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash | NCT03471364 | Malignant Neopl... | Ketoconazole Laboratory Biom... Placebo Adminis... Quality-of-Life... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer | NCT02560051 | Prostatic Neopl... | Doxorubicin Ketoconazole Docetaxel Estramustine Degarelix | 18 Years - | The University of Texas Health Science Center, Houston | |
| Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade | NCT00129207 | Tumors | bortezomib | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases | NCT03796273 | Anatomic Stage ... Astrocytoma Breast Carcinom... Glioma Invasive Breast... Oligodendroglio... Prognostic Stag... Recurrent Gliom... | Best Practice Ketoconazole | 18 Years - | Wake Forest University Health Sciences | |
| Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | NCT00003084 | Prostate Cancer | Doxorubicin Hyd... Estramustine ph... Etoposide Ketoconazole Paclitaxel Vinblastine | 18 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study | NCT00870714 | Prostate Cancer | Docetaxel Ketoconazole | 18 Years - | Kansas City Veteran Affairs Medical Center | |
| Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy | NCT00309894 | Prostate Cancer | sargramostim ketoconazole therapeutic hyd... | - 120 Years | University of California, San Francisco | |
| Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | NCT00027859 | Prostate Cancer | docetaxel estramustine ph... ketoconazole therapeutic hyd... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) | NCT01026415 | Carcinomas Disease, Hodgki... Lymphoma, Large... Lymphoma, Non-H... Neoplasms | brentuximab ved... rifampin midazolam ketoconazole brentuximab ved... | 18 Years - | Seagen Inc. | |
| A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma | NCT01765556 | Malignant Melan... | ketoconazole vemurafenib | 18 Years - | Hoffmann-La Roche | |
| Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer | NCT00447473 | Prostatic Neopl... | GM-CSF Ketoconazole Mitoxantrone | 18 Years - | The Methodist Hospital Research Institute | |
| Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | NCT00027859 | Prostate Cancer | docetaxel estramustine ph... ketoconazole therapeutic hyd... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00238225 | Unspecified Adu... | calcitriol dexamethasone ketoconazole | 18 Years - | Roswell Park Cancer Institute | |
| Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary | NCT01584297 | Granulosa Cell ... | Ketoconazole | 18 Years - | Grupo Español de Tumores Huérfanos e Infrecuentes | |
| Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | NCT00003249 | Unspecified Adu... | carboxyamidotri... chemotherapy ketoconazole | 18 Years - | National Cancer Institute (NCI) | |
| Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel | NCT00697437 | Solid Tumors | Docetaxel Ketoconazole | 18 Years - | National University Hospital, Singapore | |
| A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | NCT00006371 | Prostate Cancer | aminoglutethimi... ketoconazole therapeutic hyd... | - | H. Lee Moffitt Cancer Center and Research Institute | |
| Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | NCT02494713 | Prostate Cancer | Degarelix Doxorubicin Ketoconazole Docetaxel Estramustine | 18 Years - | The University of Texas Health Science Center, Houston | |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors | NCT01218620 | Adult Solid Neo... | Gamma-Secretase... Ketoconazole Rifampin Midazolam Hydro... Omeprazole Tolbutamide Dextromethorpha... Pharmacological... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer | NCT01324310 | Hematologic Mal... Malignant Lymph... | Romidepsin Ketoconazole | 18 Years - | Celgene | |
| Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours | NCT00750425 | Advanced Solid ... | cediranib (RECE... | 18 Years - | AstraZeneca | |
| Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00238225 | Unspecified Adu... | calcitriol dexamethasone ketoconazole | 18 Years - | Roswell Park Cancer Institute | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Ketoconazole and Dexamethasone in Prostate Cancer | NCT01036594 | Prostate Cancer | Ketoconazole Hydrocortisone Dexamethasone | 18 Years - | University of California, San Francisco | |
| Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer | NCT00002760 | Prostate Cancer | ketoconazole therapeutic hyd... Withdrawal of a... | - 120 Years | Alliance for Clinical Trials in Oncology | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) | NCT01114191 | Solid Tumors | ABT-869 ketoconazole | 18 Years - | Abbott |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
